Cargando…

Childhood Acute B-Lineage Lymphoblastic Leukemia With CDKN2A/B Deletion Is a Distinct Entity With Adverse Genetic Features and Poor Clinical Outcomes

To further emphasize the clinical–genetic features and prognosis of CDKN2A/B deletions in childhood acute lymphoblastic leukemia (ALL), we retrospectively analyzed 819 consecutive B-ALL patients treated with the Chinese Children’s Cancer Group ALL-2015 (CCCG-ALL-2015) protocol, and fluorescence in s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Jing, Guo, Ye, Yang, Wenyu, Zou, Yao, Zhang, Li, Chen, Yumei, Zhang, Yingchi, Zhu, Xiaofan, Chen, Xiaojuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195293/ https://www.ncbi.nlm.nih.gov/pubmed/35712467 http://dx.doi.org/10.3389/fonc.2022.878098

Ejemplares similares

CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients
por: Xu, Na, et al.
Publicado: (2015)

Pediatric Acute Lymphoblastic Leukemia Patients Exhibit Distinctive Alterations in the Gut Microbiota
por: Liu, Xiaoming, et al.
Publicado: (2020)

CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
por: Tu, Q, et al.
Publicado: (2018)

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
por: Genescà, E., et al.
Publicado: (2018)

Co‐occurrence of CDKN2A/B and IFN‐I homozygous deletions correlates with an immunosuppressive phenotype and poor prognosis in lung adenocarcinoma
por: Peng, Yuan, et al.
Publicado: (2022)

P368: GENOMIC LANDSCAPE OF PEDIATRIC ACUTE B LYMPHOBLASTIC LEUKEMIA IN CHINA
por: Gao, Yangyang, et al.
Publicado: (2023)

CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia
por: Jang, Woori, et al.
Publicado: (2019)

A Novel Risk Defining System for Pediatric T-Cell Acute Lymphoblastic Leukemia From CCCG-ALL-2015 Group
por: Liu, Xiaoming, et al.
Publicado: (2022)

The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia
por: González-Gil, Celia, et al.
Publicado: (2021)

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
por: Sievers, Philipp, et al.
Publicado: (2020)

CDKN2A/B Homozygous Deletions in Astrocytomas: A Literature Review
por: Yuile, Alexander, et al.
Publicado: (2023)

Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)

The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols
por: Ampatzidou, Mirella, et al.
Publicado: (2023)

Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China
por: Wei, Wei, et al.
Publicado: (2015)

Impact of CDKN2A/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma
por: Huang, L. Eric
Publicado: (2022)

Methylation of CDKN2B CpG islands is associated with upregulated telomerase activity in children with acute lymphoblastic leukemia
por: Hu, Qian, et al.
Publicado: (2017)

P1402: INFUSION OF 14 DAYS BLINATUNOMAB IN COMBINATION WITH CHEMOTHERAPY FOR 46-DAY MRD+ PEDIATRIC B-ALL PATIENTS IN INTERMEDIATE/HIGH-RISK GROUP RESULTS IN MRD CONVERSION.
por: Xue, Changwen, et al.
Publicado: (2023)

Integration of Transcriptomic Features to Improve Prognosis Prediction of Pediatric Acute Myeloid Leukemia With KMT2A Rearrangement
por: Li, Jun, et al.
Publicado: (2023)

Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia
por: Wang, Han, et al.
Publicado: (2023)

Frequent homozygous deletion of Cdkn2a/2b in tremolite‐induced malignant mesothelioma in rats
por: Okazaki, Yasumasa, et al.
Publicado: (2020)

Roles of CDKN1B in cancer?
por: Belletti, Barbara, et al.
Publicado: (2015)

Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance
por: Rosenberg, A S, et al.
Publicado: (2017)

Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Xu, Na, et al.
Publicado: (2016)

Gene Deletions and Prognostic Values in B-Linage Acute Lymphoblastic Leukemia
por: Fang, Qiuyun, et al.
Publicado: (2021)

IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan
por: Asai, Daisuke, et al.
Publicado: (2013)

Association of the independent polymorphisms in CDKN2A with susceptibility of acute lymphoblastic leukemia
por: Zhou, Xueyan, et al.
Publicado: (2018)

Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population
por: Gutierrez-Camino, Angela, et al.
Publicado: (2017)

Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
por: Wei, Guoqing, et al.
Publicado: (2017)

MPC-10 Prognostic analysis in IDH mutant astrocytoma patient with CDKN2A/B homozygous deletion
por: Yanagisawa, Shunsuke, et al.
Publicado: (2021)

Poor Performer: A Distinct Entity in Cochlear Implant Users?
por: Völter, Christiane, et al.
Publicado: (2022)

A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology
por: Hungate, Eric A., et al.
Publicado: (2016)

Pediatric non–Down’s syndrome acute megakaryoblastic leukemia patients in China: A single center's real-world analysis
por: Zhang, Aoli, et al.
Publicado: (2022)

Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia
por: Yao, Qiu-Mei, et al.
Publicado: (2016)

Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children
por: Ruan, Yang, et al.
Publicado: (2023)

Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma
por: Patel, Shyamal, et al.
Publicado: (2020)

P511: INTEGRATION OF TRANSCRIPTOMIC FEATURES IMPROVES PROGNOSIS PREDICTION OF PEDIATRIC ACUTE MYELOID LEUKEMIA WITH KMT2A REARRANGEMENTS
por: LI, Jun, et al.
Publicado: (2023)

The functional role of inherited CDKN2A variants in childhood acute lymphoblastic leukemia
por: Li, Chunjie, et al.
Publicado: (2021)

Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma
por: Stenman, Adam, et al.
Publicado: (2021)

CDKN2A/B deletions are strongly associated with meningioma progression: a meta-analysis of individual patient data
por: Wach, Johannes, et al.
Publicado: (2023)

IKZF1 deletions associate with CRLF2 overexpression leading to a poor prognosis in B-cell precursor acute lymphoblastic leukaemia
por: Maciel, Ana Luiza Tardem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b1kef6iceql3nu97ug7qdvkqp1